Ward P A, Becker E L
J Exp Med. 1968 Apr 1;127(4):693-709. doi: 10.1084/jem.127.4.693.
As shown previously, immune complexes engender in rabbit serum a factor capable of inducing chemotaxis of rabbit polymorphonuclear leukocytes. This chemotactic factor consists of a complex of the fifth, sixth, and seventh components of complement. As demonstrated here, the polymorphonuclear leukocytes incubated with such treated rabbit serum lose their ability to respond chemotactically to the chemotactic factor. They are "deactivated." The process of "deactivation" is a function of the duration of contact of the cells with, and the concentration of, the treated serum. There is a parallelism between the time course of deactivation and of chemotaxis, as well as the dose-response curves for the two processes. Chemotactic factor purified by isoelectric precipitation and ion-exchange chromatography produces deactivation in the same manner as the treated serum. The deactivating activity requires, as does the chemotactic factor, the sixth component of complement; like the chemotactic factor, it is heat-stable and nondialyzable. Deactivation is prevented by the same phosphonate esters shown previously to prevent chemotaxis by the complement-associated chemotactic factor. The profiles of the phosphonates in protecting against deactivation are the same as the profiles for the chemotactic factor-dependent inhibition of chemotaxis. Aromatic amino acid derivatives prevent both chemotaxis and deactivation. We conclude from this evidence that the chemotactic factor is able to deactivate or induce chemotaxis depending upon experimental conditions. The fact that the profiles given by the phosphonates for protection against chemotactic factor-dependent deactivation and for chemotactic factor-dependent inhibition of chemotaxis are the same indicates that the "activatable esterase" is involved in both processes. Acetate esters such as ethyl acetate and others shown previously to prevent chemotaxis by inhibiting the "activated esterase" do not prevent deactivation. This indicates that deactivation can occur without participation of the latter enzyme, implying that deactivation involves only a part of the biochemical mechanism of chemotaxis. The protection against deactivation afforded by aromatic amino acid derivatives is specific, insofar as nonaromatic amino compounds and simple acetate esters have no effect. In addition, as stated, the aromatic amino acid derivatives inhibit deactivation and chemotaxis by the chemotactic factor. This latter finding, together with the demonstration of the involvement of the activatable esterase in both deactivation and chemotaxis, suggests that the activatable esterase of the rabbit polymorphonuclear leukocyte is a serine esterase with a special affinity for aromatic amino acid derivatives.
如前所示,免疫复合物在兔血清中产生一种能够诱导兔多形核白细胞趋化性的因子。这种趋化因子由补体的第五、第六和第七成分组成。如本文所示,与这种经处理的兔血清一起孵育的多形核白细胞失去了对趋化因子作出趋化反应的能力。它们被“失活”。“失活”过程是细胞与经处理血清的接触持续时间和血清浓度的函数。失活的时间进程与趋化性的时间进程之间存在平行关系,以及这两个过程的剂量反应曲线。通过等电沉淀和离子交换色谱法纯化的趋化因子以与经处理血清相同的方式产生失活。失活活性与趋化因子一样,需要补体的第六成分;与趋化因子一样,它是热稳定的且不可透析的。先前显示可防止补体相关趋化因子趋化作用的相同膦酸酯可防止失活。膦酸酯在防止失活方面的作用模式与趋化因子依赖性趋化抑制的作用模式相同。芳香族氨基酸衍生物可同时防止趋化和失活。根据这些证据,我们得出结论,趋化因子能够根据实验条件使细胞失活或诱导趋化。膦酸酯在防止趋化因子依赖性失活和趋化因子依赖性趋化抑制方面给出的作用模式相同这一事实表明,“可激活酯酶”参与了这两个过程。先前显示可通过抑制“激活酯酶”来防止趋化的乙酸乙酯等乙酸酯并不能防止失活。这表明失活可以在后者酶不参与的情况下发生,这意味着失活仅涉及趋化生化机制的一部分。芳香族氨基酸衍生物对失活的保护作用是特异性的,因为非芳香族氨基化合物和简单的乙酸酯没有作用。此外,如前所述,芳香族氨基酸衍生物抑制趋化因子的失活和趋化作用。后一发现,连同可激活酯酶参与失活和趋化作用的证明,表明兔多形核白细胞的可激活酯酶是一种对芳香族氨基酸衍生物具有特殊亲和力的丝氨酸酯酶。